Stifel Initiates Coverage On ON Semiconductor with Hold Rating, Announces Price Target of $45

Stifel analyst Tore Svanberg initiates coverage on ON Semiconductor (NASDAQ:ON) with a Hold rating and announces Price Target of $45.

byBenzinga Newsdesk

October 14, 2021

1 minute read

Stifel analyst Tore Svanberg initiates coverage on ON Semiconductor (NASDAQ:ON) with a Hold rating and announces Price Target of $45.

Kiromic BioPharma Q1 EPS $(0.48) Up From $(0.53) YoY

By Benzinga Newsdesk

Today, 5:06 AM

Kiromic BioPharma (NASDAQ:KRBP) reported quarterly losses of $(0.48) per share. This is a 9.43 percent increase over losses of $(0.53) per share from the same period last year.

KRBP

Wayfair Stock Jumps On Q2 Earnings Beat, Rising Active Customers

By Shivani Kumaresan

Today, 5:06 AM

Wayfair Inc (NYSE:W) reported a second-quarter FY21 sales decline of 10.4% year-on-year, to $3.86 billion, missing the analyst consensus of $3.96…

Morgan Stanley Maintains Underweight on Roku, Raises Price Target to $325

By Benzinga Newsdesk

Today, 5:06 AM

Morgan Stanley maintains Roku (NASDAQ:ROKU) with a Underweight and raises the price target from $300 to $325.

ROKU

Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More

By Lara Goldstein

Today, 5:06 AM

Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's Senate Health Committee.

PSIL

Stifel Initiates Coverage On ON Semiconductor with Hold Rating, Announces Price Target of $45

Related Posts

Kiromic BioPharma Q1 EPS $(0.48) Up From $(0.53) YoY

Wayfair Stock Jumps On Q2 Earnings Beat, Rising Active Customers

Morgan Stanley Maintains Underweight on Roku, Raises Price Target to $325

Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More